HIV Drugs for Poor Found Resold in Europe
Nearly $18 million worth of reduced-price HIV drugs intended for impoverished Africans has been intercepted by profiteers and shipped back to Europe to be sold at marked-up prices, Dutch officials and the manufacturer said.
Nearly a quarter of the supply of the drug Combivir intended for African patients has not reached them in the last year, said the manufacturer, GlaxoSmithKline.
Instead, it and two other Glaxo HIV drugs were sold in Germany, the Netherlands, Britain and Switzerland by European wholesalers now under investigation.
More to Read
Start your day right
Sign up for Essential California for news, features and recommendations from the L.A. Times and beyond in your inbox six days a week.
You may occasionally receive promotional content from the Los Angeles Times.
